Silvercrest Asset Management Group LLC Organon & Co. Transaction History

Silvercrest Asset Management Group LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$16.59 - $23.77 $10,451 - $14,975	630 Added 6.39%	10,489 $182,000
Q2 2023 Aug 14, 2023	SELL	$19.27 - $24.63 $9,789 - $12,512	-508 Reduced 4.9%	9,859 $205,000
Q1 2023 May 15, 2023	SELL	$21.42 - $32.08 $9,060 - $13,569	-423 Reduced 3.92%	10,367 $243,000
Q4 2022 Feb 14, 2023	SELL	$23.31 - $28.61 $40,349 - $49,523	-1,731 Reduced 13.82%	10,790 $301,000
Q3 2022 Nov 14, 2022	SELL	$23.4 - $34.25 $42,049 - $61,547	-1,797 Reduced 12.55%	12,521 $293,000
Q2 2022 Aug 15, 2022	SELL	$31.66 - $38.9 $72,121 - $88,614	-2,278 Reduced 13.73%	14,318 $483,000
Q1 2022 May 16, 2022	SELL	$30.45 - $39.36 $1,278 - $1,653	-42 Reduced 0.25%	16,596 $580,000
Q4 2021 Feb 14, 2022	SELL	$28.67 - $37.13 $56,651 - $73,368	-1,976 Reduced 10.62%	16,638 $507,000
Q3 2021 Nov 15, 2021	SELL	$28.63 - $35.64 $510,988 - $636,102	-17,848 Reduced 48.95%	18,614 $611,000
Q2 2021 Aug 16, 2021	BUY	$28.45 - $38.0 $1.04 Million - $1.39 Million	36,462 New	36,462 $1.1 Million

792

203M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.96B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.